Covered recipient · General Payments record
CHELSEA LUNDGREN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2023
$329.98
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $202.15 | 9 |
| Education | $48.84 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ITI, Inc. | $90.15 | 3 |
| Alkermes, Inc. | $41.76 | 2 |
| Teva Pharmaceuticals USA, Inc. | $31.28 | 1 |
| DEXCOM, INC. | $28.13 | 1 |
| Otsuka America Pharmaceutical, Inc. | $25.03 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.66 | 1 |
| Lilly USA, LLC | $16.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $18.34 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1061172409 | CMS |
| Alkermes, Inc. | $23.42 | 07/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022863249 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.66 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996768753 | CMS |
| Dexcom, Inc. | $28.13 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054902713 | CMS |
| ITI, Inc. | $26.75 | 05/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1041005817 | CMS |
| ITI, Inc. | $14.56 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1041005823 | CMS |
| ITI, Inc. | $48.84 | 06/30/2023 | Education | Undisputed | 01/23/2026 | 1041005827 | CMS |
| Lilly USA, LLC | $16.98 | 01/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032859391 | CMS |
| Otsuka America Pharmaceutical, Inc. | $25.03 | 07/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015391665 | CMS |
| Teva Pharmaceuticals USA, Inc. | $31.28 | 07/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056978999 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.